3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neoplasms
4
Depression
4
Head and Neck Neoplasms
3
Breast Neoplasms
3
Triple Negative Breast Neoplasms
2
Fatigue
2
Anxiety Disorders
2
Uterine Cervical Neoplasms
1
Urogenital Neoplasms
1
Urinary Bladder Neoplasms
1
Sleep Wake Disorders
1
Recurrence
1
Radiation Fibrosis Syndrome
1
Prostatic Neoplasms
1
Prostatic Hyperplasia
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Patient Acceptance of Health Care
1
Pain
1
Neoplasm Metastasis
1
Myasthenia Gravis
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma
1
Lung Neoplasms
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Kidney Calculi
1
Inflammatory Breast Neoplasms
1
Immune Checkpoint Inhibitor-Induced Dermatitis
1
Health Education
1
Constriction, Pathologic
1
Interventions
cabozantinib
5
Nivolumab
4
Ipilimumab
4
Axitinib
4
pembrolizumab
3
Blood Specimen Collection
3
zimberelimab
2
atezolizumab
2
Surveys and Questionnaires
2
Sunitinib
2
Irinotecan
2
temsirolimus
1
spartalizumab
1
salicylhydroxamic acid
1
palbociclib
1
orellanine
1
olaparib
1
liposomal doxorubicin
1
lenvatinib
1
gallium Ga 68 dotatate
1
fludarabine
1
brodalumab
1
belzutifan
1
aldesleukin
1
adagrasib
1
Vincristine
1
Temozolomide
1
Taxes
1
Selenomethionine
1
Ropivacaine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Kidney Neoplasms
×
Therapeutics
×
90 days
×
Clear all
No trials found.